Polyrizon announces appointment of vp of regulatory affairs and quality assurance

Raanana, israel, dec. 13, 2024 (globe newswire) -- polyrizon ltd. (nasdaq: plrz) (the "company" or "polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announces today the appointment of asaf azulay, the managing director of eurofins' li-med team, to its leadership as its vp of regulatory affairs and quality assurance (ra/qa). this strategic appointment reflects polyrizon's ongoing commitment to maintaining the highest industry standards as it advances its pipeline of cutting-edge solutions.
PLRZ Ratings Summary
PLRZ Quant Ranking